How do we choose a therapeutic regimen in cystic fibrosis?

How do we choose a therapeutic regimen in cystic fibrosis?

Multiple vaccines: how do we choose?

BACKGROUND As preventive medicine is a cornerstone of managed care, most health plans have traditionally featured automatic vaccine coverage routed through the medical benefit. However, with the advent of emerging vaccines, managed care stakeholders must revise decision-making processes and choose among multiple products targeting the same disease. OBJECTIVE To review the motivating forces be...

Cystic Fibrosis: How do CFTR mutations cause cystic fibrosis?

Two major discoveries have transformed our understanding of cystic fibrosis, a genetic disease in which thick secretions accumulate in airways, digestive organs and sperm duct. The first was that cystic fibrosis involves a basic defect in epithelial ion transport [1], which is manifested primarily as the loss of chloride conductance [2]. The connection between the loss of epithelial chloride co...

How Can We Target Pulmonary Inflammation in Cystic Fibrosis?

With each year our enhanced understanding of the pathogenesis of cystic fibrosis (CF) is challenged by new discoveries related to the increasingly complex nature of this disorder. Originally described as a genetic disorder principally due to defective chloride ion conductance at epithelial surfaces and a predisposition to bacterial colonization have been moved into the category of an inflammato...

How do clinicians choose antidepressants?

Research suggests no difference in efficacy be tween tricyclic and related antidepressant drugs. The British National Formulary (1993) lists 21 different antidepressants. Reviews of antidepres sant treatment suggest that choice of antidepres sant should be made on the grounds of previous drug exposure and side effect profiles of different drugs. At present there are no clinical guidelines to in...